Atrial Appendage Closure Prospective Observational Study
| Status: | Recruiting |
|---|---|
| Conditions: | Atrial Fibrillation |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 7/11/2015 |
| Start Date: | June 2012 |
| End Date: | December 2016 |
LARIAT: Atrial Appendage Closure Prospective Observational Study
The purpose of this research is to monitor how well patients do after surgery for treatment
of left atrial appendage (LAA).
of left atrial appendage (LAA).
Patients will be followed in an observational study. We propose to do a single follow-up TEE
at 3 to 6 months (this is standard of care) to confirm LAA (left atrial appendage)
occlusion. The TEE is not mandatory (this is not a clinical trial), but will be strongly
recommended to patients to confirm the efficacy of treatment. This will help confirm whether
patients may safely remain off anticoagulation. The risks of TEE are a less than 1 in 1000
risk of death, and a 1% or less risk of a major complication, such as esophageal
perforation.
at 3 to 6 months (this is standard of care) to confirm LAA (left atrial appendage)
occlusion. The TEE is not mandatory (this is not a clinical trial), but will be strongly
recommended to patients to confirm the efficacy of treatment. This will help confirm whether
patients may safely remain off anticoagulation. The risks of TEE are a less than 1 in 1000
risk of death, and a 1% or less risk of a major complication, such as esophageal
perforation.
Inclusion Criteria:
- Patients with Atrial fibrillation
- Are poor candidates to take warfarin
- Have elected to undergo a LARIAT procedure
Exclusion Criteria:
- none
We found this trial at
1
site
Click here to add this to my saved trials
